Atlas Trials

Extension Study of Liposomal Amikacin for Inhalation in Cystic Fibrosis (CF) Patients With Chronic Pseudomonas Aeruginosa (Pa) Infection

Clinical trial NCT01316276 · COMPLETED

Trial details

NCT number
NCT01316276
Sponsor
Insmed Incorporated
Status
COMPLETED
Phase
Phase 3
Study type
INTERVENTIONAL
Cystic Fibrosis
Start date
2012-10-05
Primary completion
2015-07-16
Enrollment
206

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.